Skip to main content
1st paper on the Global Rheumatology Alliance @rheum_covid registry published in Lancet Rheumatology. @ April 1st 110 COVID-19 Rheum pts enrolled from

Dr. John Cush RheumNow

6 years 5 months ago
1st paper on the Global Rheumatology Alliance @rheum_covid registry published in Lancet Rheumatology. @ April 1st 110 COVID-19 Rheum pts enrolled from Europe, N&S America, Asia, Africa, Oceania; now up to 487 with 9894 in the patient survey. https://t.co/RI2AKsyf5T
RT @LupusCanada: @LupusCanada has enhanced our survey to better understand the current situation and evolution of HcQ availability in Canad…

Lupus Canada LupusCanada

6 years 5 months ago
@LupusCanada has enhanced our survey to better understand the current situation and evolution of HcQ availability in Canada. Please share this survey with anyone impacted by this issue https://t.co/0ImHloC0JZ #LetsTalkLupus #LupusCanada #lupus
Neurologic side effects of TNFi are rare; Sweden/Denmark population study shows TNFi in AS/PsA, but not in RA, associated with increased risk of neuro

Dr. John Cush RheumNow

6 years 5 months ago
Neurologic side effects of TNFi are rare; Sweden/Denmark population study shows TNFi in AS/PsA, but not in RA, associated with increased risk of neuroinflammatory events (0.59 to 0.87 /1000PY) with TNFi and 0.19-0.40/1000PY in unexposed https://t.co/FeRtKSspXj
article in A&R details the Immunopathology, inflammatory mediators operative in cytokine storm syndrom of COVID-19 (and MAS/HLH), how to assess th

Dr. John Cush RheumNow

6 years 5 months ago
article in A&R details the Immunopathology, inflammatory mediators operative in cytokine storm syndrom of COVID-19 (and MAS/HLH), how to assess them and treatment options. Smart and timely article. (free read) https://t.co/3tsEVYMVRM
Check out my take on the new ACR COVID-19 Guidance for Rheumatic Disease Patients - great suggestions; but I do have a few thoughts that differ....wha

Dr. John Cush RheumNow

6 years 5 months ago
Check out my take on the new ACR COVID-19 Guidance for Rheumatic Disease Patients - great suggestions; but I do have a few thoughts that differ....what do you think? https://t.co/8srDPYRo0b
RT @KDAO2011: Dr M Drazner ⁦@UTSWNews⁩ Grand Rounds on #COVID19 pts w/cardiac involvement may be afebrile ⁦@RheumNow⁩ https://t.co/nKUJe1H…

k dao KDAO2011

6 years 5 months ago

Dr M Drazner ⁦@UTSWNews⁩ Grand Rounds on #COVID19 pts w/cardiac involvement may be afebrile ⁦@RheumNow⁩ https://t.co/nKUJe1HIdl

Dr. Jack Cush reviews the appproach to evaluating fever in adults suspected of having a rheumatic disease, Stills disease or autoinflammatory conditions. Presentations, fever duration, disease criteria and genetic testing are discussed.
Dr. Jack Cush reviews the news, journal articles and new ACR COVID-19 guidelines from the past week on RheumNow.com.
TNR Grand Rounds - Evaluation of Febrile Rheumatic Patients
Fever Duration, Disease Criteria & Genetic Testing
COVID-19 is not going to suddenly end on June 1st. This is a long haul change and you need to be prepared for the aftershocks and fallout. It’s time to be be a Marine and ”Improvise, Adapt, and Overcome”.
×